Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
CMEA Ventures is a San Francisco based venture capital firm that specializes in high technology, life sciences, and alternative energy investments. The firm invests in both early and late stage companies, and actively partners with its extended network of companies, other VC firms, institutional investors, strategic partners as well as entrepreneurs. CMEA was originally formed as an affiliate of New Enterprise Associates (NEA) in 1989 and became independent in 1997. CMEA currently has 74 portfolio companies, 6 funds and manages $1.2 billion of venture capital.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2004 | Inovys | Series C | 0 |
9/2014 | Odyssey Logistics &a; Technology Corporation | Venture Round | 40M |
1/2014 | Odyssey Logistics &a; Technology Corporation | Venture Round | 48M |
1/2005 | Predix Pharmaceuticals | Series C | 0 |
8/2004 | Kalypsys | Series B | 29M |
8/2003 | Myogen | Series D | 40M |
6/2008 | VeraLight | Series C | 0 |
1/2003 | Raven Biotechnologies | Series C | 0 |
1/2001 | Salmedix | Series A | - |
10/2003 | RF Magic | Series C | 0 |
11/2007 | Ensemble Discovery | Series B | 15M |
1/2006 | Solyndra | Series B | 79.2M |
9/2007 | Odyssey Logistics &a; Technology Corporation | Series C | 5M |
9/2002 | Alexza Pharmaceuticals | Series A | 0 |
12/2010 | Odyssey Logistics &a; Technology Corporation | Venture Round | 20M |
2/2005 | Odyssey Logistics &a; Technology Corporation | Series B | 11M |
9/2003 | Odyssey Logistics &a; Technology Corporation | Series A | 24.3M |
10/2001 | Altus Pharmaceuticals | Series B | 50.8M |
4/2007 | Superprotonic | Series B | 16.2M |
4/2002 | Dassault Systemes | Venture Round | 14.1M |
11/2006 | Tetraphase Pharmaceuticals | Series A | 10M |
9/2009 | Tetraphase Pharmaceuticals | Series B | 0 |
10/2006 | VeraLight | Series B | 0 |
8/2000 | E-Markets | Series B | 10M |
5/2005 | Bayhill Therapeutics | Series B | 35.4M |
1/2004 | Bayhill Therapeutics | Series A | - |
6/2003 | Phenomix | Series A | 11.6M |
7/2007 | Telsima | Debt Financing | 25M |
11/2004 | Mojo Networks | Series A | 10.3M |
2/2002 | PathScale | Series A | 1.5M |
1/2006 | Entropic | Series C | 0 |
5/2004 | PathScale | Series C | 15M |
2/2003 | PathScale | Series B | 12.5M |
11/2006 | Dassault Systemes | Venture Round | - |
7/2004 | Phenomix | Series A | 2M |
8/2007 | MailExpress | Series B | 15M |
11/2004 | BioMimetic Therapeutics | Series C | 25.7M |
2/2008 | Pyxis Technology | Series B | 5.3M |
7/2003 | Sanera Systems | Series C | 35M |
7/2000 | Alliance Fiber Optic Products | Venture Round | 27.5M |
3/2002 | Phenomix | Series A | 12M |
3/2002 | Siros Technologies | Venture Round | 17M |
1/2003 | Perlegen Sciences | Series C | 30M |
1/2001 | Ensim Corporation | Venture Round | 0 |
1/2005 | Alexza Pharmaceuticals | Series D | 0 |
8/2001 | Myogen | Series D | 52.4M |
4/2006 | Bayhill Therapeutics | Venture Round | 15.8M |
2/2000 | ChemConnect | Private Equity Round | 0 |
11/2001 | iSuppli | Series C | - |
11/2000 | iSuppli | Series B | 30M |
8/2003 | CPlane | Series D | 2.5M |
3/2009 | Draths Corporation | Series C | 7.8M |
7/2002 | AWR Corporation | Series B | 7.4M |
11/2005 | Pyxis Technology | Series A | 250k |
10/2008 | Arcadia Biosciences | Private Equity Round | 15M |
6/2010 | Solyndra | Private Equity Round | 175M |
3/2005 | NovX | Series B | 6.4M |
5/2004 | Altus Pharmaceuticals | Series C | 0 |
4/2005 | Phenomix | Series B | 20M |
1/2001 | CPlane | Series C | 25M |
5/2008 | NovX | Series C | 0 |
5/2005 | BioMimetic Therapeutics | Series C | 11.8M |
6/2002 | Salmedix | Series B | 27.5M |
12/2007 | Arcion Therapeutics | Series A | 8.8M |
5/2005 | Symwave | Series B | 6.1M |
7/2011 | SurgiQuest | Series C | 19M |
2/2000 | Xenoport | Series A | 15.9M |
8/2007 | NovX | Debt Financing | 0 |
2/2007 | Visiogen | Venture Round | 24M |
10/2008 | InSound Medical | Series E | 13M |
9/2014 | Odyssey Logistics &a; Technology Corporation | Venture Round | 0 |
1/2014 | Odyssey Logistics &a; Technology Corporation | Venture Round | 0 |
7/2011 | SurgiQuest | Series C | 0 |
12/2010 | Odyssey Logistics &a; Technology Corporation | Venture Round | 0 |
6/2010 | Solyndra | Private Equity Round | 0 |
9/2009 | Tetraphase Pharmaceuticals | Series B | 0 |
3/2009 | Draths Corporation | Series C | 0 |
10/2008 | Arcadia Biosciences | Private Equity Round | 0 |
10/2008 | InSound Medical | Series E | 0 |
6/2008 | VeraLight | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|